NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells

Journal: Journal of Experimental Medicine

Published: 2020-08-03

DOI: 10.1084/jem.20190133

Affiliations: 14

Authors: 19

Go to article
Institutions Share
Innate Immunity in Rheumatic Diseases, DRFZ, Germany 0.32
Research Group Therapeutic Gene Regulation, DRFZ, Germany 0.11
I. Medical Clinic and Polyclinic, UHH, Germany 0.11
Department for Histology and Embryology, UNIRI, Croatia 0.08
Charité Medical Department I - Division of Gastroenterology, Infectiology and Rheumatology, Germany 0.05
Research Group Cell Biology, DRFZ, Germany 0.05
LICR Brussels Branch, Belgium 0.05
Institut Necker Enfants Malades (INEM), France 0.05
Institute of Immunology and Immunotherapy, UB, United Kingdom (UK) 0.05
Center for Proteomics (CAPRI), UNIRI, Croatia 0.03
Pitzer Laboratory Osteoarthritis Research, DRFZ, Germany 0.03
Charité Medical Department - Division of Rheumatology and Clinical Immunology, Germany 0.03
Yale Department of Immunobiology, United States of America (USA) 0.03
Yale University, United States of America (USA) 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER